advertisement
Gill SS 12
Showing records 1 to 12 | Display all abstracts from Gill SS106579 Association of topical glaucoma medications with lacrimal drainage obstruction and eyelid malposition
Quinn MP
Eye 2023; 37: 2233-2239
106613 Evolution of first-line glaucoma therapy, 2007-2018: a population-based analysis
Doliszny K
Canadian Journal of Ophthalmology 2024; 59: 89-95
106579 Association of topical glaucoma medications with lacrimal drainage obstruction and eyelid malposition
Quinn MP
Eye 2023; 37: 2233-2239
106613 Evolution of first-line glaucoma therapy, 2007-2018: a population-based analysis
Quinn MP
Canadian Journal of Ophthalmology 2024; 59: 89-95
106579 Association of topical glaucoma medications with lacrimal drainage obstruction and eyelid malposition
Kratky V
Eye 2023; 37: 2233-2239
106613 Evolution of first-line glaucoma therapy, 2007-2018: a population-based analysis
Quinn MP; El-Defrawy SR
Canadian Journal of Ophthalmology 2024; 59: 89-95
106579 Association of topical glaucoma medications with lacrimal drainage obstruction and eyelid malposition
Whitehead M; Gill SS
Eye 2023; 37: 2233-2239
106613 Evolution of first-line glaucoma therapy, 2007-2018: a population-based analysis
Gill SS
Canadian Journal of Ophthalmology 2024; 59: 89-95
106579 Association of topical glaucoma medications with lacrimal drainage obstruction and eyelid malposition
McIsaac MA
Eye 2023; 37: 2233-2239
106613 Evolution of first-line glaucoma therapy, 2007-2018: a population-based analysis
Whitehead M
Canadian Journal of Ophthalmology 2024; 59: 89-95
106579 Association of topical glaucoma medications with lacrimal drainage obstruction and eyelid malposition
Campbell RJ
Eye 2023; 37: 2233-2239
106613 Evolution of first-line glaucoma therapy, 2007-2018: a population-based analysis
Johnson D; Campbell RJ
Canadian Journal of Ophthalmology 2024; 59: 89-95
